Recently, nuclear phosphofructokinase, platelet (PFKP) was reported to stimulate CXCR4 expression through c‐MYC activity in T‐ALL and lymphoma cells [26]. This evidence concerns the gene CXCR4 and acute lymphoblastic leukemia.